Modified antigen-presenting cells

Details Modified antigen-presenting cells Modified antigen-presenting cells

2011-06-07

2011-06-07

Juedes, Amy E (Department: 1644)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

C435S455000, C435S366000

Reexamination Certificate

active

07955845

ABSTRACT:
The invention relates to antigen-presenting cells having specificity against a selected antigen and methods for making the cells. The invention also relates to a method of selecting efficient antigen-presenting cells using reporter fusion constructs. The highly efficient antigen-presenting cells of the invention will provide a therapeutic strategy of modulating immune responses for a variety of diseases.

REFERENCES:
patent: 5858776 (1999-01-01), Ostrand-Rosenberg et al.
patent: 5962320 (1999-10-01), Robinson
patent: 6187307 (2001-02-01), Cohen
patent: 6194205 (2001-02-01), Staege et al.
patent: 6251627 (2001-06-01), Cai et al.
patent: 6319709 (2001-11-01), Ostrand-Rosenberg et al.
patent: 6620912 (2003-09-01), Young et al.
patent: 7001733 (2006-02-01), Ferrick et al.
patent: WO 9529236 (1995-11-01), None
patent: WO 96/27392 (1996-09-01), None
patent: WO 97/29183 (1997-08-01), None
Ginsberg, 1996, The ups and downs of adenovirus vectors. Bull NY Acad. Med. vol. 73:53-8.
Latouche et al., 2000, Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells. Nature Biotech. vol. 18:405-409.
Zoeten et al., 1998, Resistance to Melanoma in Mice immunized with semiallogeneic fibroblasts transfected with DNA from mouse melanoma cells. J. Immunol. vol. 160: 2915-22.
Hood et al., 1983, Genes of the major histocompatibility complex of the mouse. Ann. Rev. Immunol. vol. 1:529-68.
Auffray et al., 1986, Molecular genetics of the human major histocompatibility complex, Adv. Hum. Genet. vol. 15:197-247.
Scholler et al., 2001, J. Immunol. vol. 166: 3865-72.
Janeway and Travers, 1997, Immunobiology, p. 4:7.
Lohmann et al., 2000, Cancer Gene Therapy, vol. 7: 605-614.
Stauss, et al.; “Induction of cytotoxic T lymphocytes with peptides in vitro: Identification of candidate T-cell epitopes in human papilloma virus”;Proc. Natl. Acad. Sci. USA; (1992); 89: 7871-7875.
Carbone, et al.; “Induction of Cytotoxic T Lymphocytes by Primary in vitro Stimulation with Peptides”;J. Exp. Med.; (1988); 167: 1767-1779.
Trowsdale & Campbell; “Complexity in the Major Histocompatibility Complex”;Euro. J. Immunogenetics; (1993); 19: 45-55.
Speiser, et al.; “Discrepancy between in vitro Measurable and in vivo Virus Neutralizing Cytotoxic T Cell Reactivities”;J. Immunol.; (1992); 149: 972-80.
Braciale; “Antigen processing for presentation by MHC class I molecules”;Curr. Opin. Immunol.; (1992); 4: 59-62.
Lehner and Trowsdale; “Antigen presentation: Coming out Gracefully”;Curr. Biol. (1998); 8: R605-R608.
Wick & Ljunggren; “Processing of bacterial antigens for peptide presentation on MHC class I molecules”;Immunol. Rev.; (1999); 172: 153-62.

Affiliated with

Also associated with

Rating

Modified antigen-presenting cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified antigen-presenting cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified antigen-presenting cells will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2671560